UNIRAD: Multicenter, double-blind, phase III study of everolimus plus ongoing adjuvant therapy in ER+, HER2- breast cancer.
Thomas Denis Bachelot
Employment or Leadership Position - Novartis
Honoraria - Novartis
Research Funding - Novartis
Sylvie Chabaud
No relevant relationships to disclose
Anne-Laure Martin
No relevant relationships to disclose
J Lemonnier
No relevant relationships to disclose
Mario Campone
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Fabrice Andre
Consultant or Advisory Role - Novartis
Honoraria - Novartis